Mckesson

FDA Regulatory Profile

Mckesson appears in FDA public data with 4 recalls — including 1 Class I (most serious) —, 5 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0714-2026, Class II) was initiated on June 10, 2026. Its most recent 510(k) clearance was granted on August 2, 1977.

Summary

Total Recalls
4 (1 Class I)
510(k) Clearances
5
Inspections
5
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0714-2026Class IIGemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous InfusioJune 10, 2026
D-0353-2026Class IUDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, ManufactuJanuary 16, 2026
D-0213-2025Class IIInflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx oJanuary 17, 2025
D-0005-2015Class IIAmiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured foSeptember 12, 2014

Recent 510(k) Clearances

K-NumberDeviceDate
K771175RESUSCITATOR, MS30August 2, 1977
K761196NITROUS OXIDE SCAVENGING MASKDecember 13, 1976
K761195ESOPHAGEAL OBTURATION AIRWAYDecember 9, 1976
K761194HLR QUICK-FIT HEART-LUNG RESUSCITATORDecember 9, 1976
K760017CONSIOUS SEDATION (ANALOR P-76)July 20, 1976